Research & Development

aⅴ无码天堂2018在线亚洲天堂a2018无码伊人成人综合我国科研人员研制出新型材料 或应用于机器人领域


  小蟲不但夸張的用手指比劃水溝的寬度,一邊敏捷地在地上跳來跳去,表示自己能跳很寬的水溝。   平叟滿含深意的瞅瞅雲瑯身邊的老虎,就不再提了,話鋒一轉,把一封帛書放在雲瑯面前道︰“這是卓氏鐵器作坊的兩成份子,你看看是否滿意,滿意了,我們再說別的。”aⅴ无码天堂2018在线   且不論是誰的人情。亚洲天堂a2018无码   胥吏笑吟吟的道︰“下官王溫舒!”   霍去病疲憊的搖搖頭道︰“我也想養只老虎。”伊人成人综合   僅有的一點綢布,被丑庸,小蟲理所當然的瓜分了,連小蟲老娘都沒資格領。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo